title: Effects of oral clonidine premedication on concentrations of cortisol and monoamine neurotransmitters and their metabolites in cerebrospinal fluid and plasma.
abstract: Forty-two healthy male patients (aged 19-40 years), undergoing orthopaedic surgery under spinal anaesthesia (3 ml isobaric 0.5% bupivacaine), were given clonidine 4.5 micrograms kg-1 orally either 2 (Group I, n = 10) or 4 (Group II, n = 10) hours before the operation, diazepam 0.15 mg kg-1 orally (Group III, n = 10) or a placebo tablet (Group IV, n = 12) 2 h before the operation. Plasma concentrations of cortisol, noradrenaline (NA), adrenaline (A), 3,4-dihydroxyphenylglycol (DHPG) and dihydroxyphenylacetic acid (DOPAC) were assayed from venous blood samples just before premedication and just before the spinal block. Cerebrospinal fluid (CSF) concentrations of cortisol, tryptophan, 5-hydroxyindoleacetic acid and catecholamine metabolites were assayed from a sample taken before the spinal block. The plasma NA concentrations of the patients in the groups receiving clonidine decreased clearly compared with the other groups (P less than 0.05). The NA metabolite DHPG was also lower in Groups I and II than in Group III (P less than 0.05) after premedication. Plasma A concentrations were lower in Groups I and III than in Group IV (P less than 0.05). The CSF concentrations of the different substances were similar in all groups. In Group I the sensory blockade lasted significantly longer than in Group III (P less than 0.05) and the mean duration of motor blockade was longer in Group I than in Groups III and IV (P less than 0.05). Two patients in both clonidine groups developed bradycardia (heart rate less than 45 min-1) requiring atropine treatment.(ABSTRACT TRUNCATED AT 250 WORDS)
authors: Department of Anaesthesiology, Surgical Hospital, Helsinki, Finland.
authors: J
authors: J
authors: Pouttu
authors: M
authors: M
authors: Tuominen
authors: M
authors: M
authors: Scheinin
authors: P H
authors: PH
authors: Rosenberg
mesh_terms: D015102:3,4-Dihydroxyphenylacetic Acid / Q000097:blood; D000284:Administration, Oral; D000328:Adult; D000775:Anesthesia, Spinal; D002986:Clinical Trials as Topic; D003000:Clonidine / Q000008:administration & dosage / Q000494:pharmacology*; D003975:Diazepam / Q000008:administration & dosage / Q000494:pharmacology; D004311:Double-Blind Method; D004837:Epinephrine / Q000097:blood / Q000134:cerebrospinal fluid / Q000378:metabolism*; D006801:Humans; D006854:Hydrocortisone / Q000097:blood / Q000134:cerebrospinal fluid / Q000378:metabolism*; D006897:Hydroxyindoleacetic Acid / Q000134:cerebrospinal fluid; D008297:Male; D008734:Methoxyhydroxyphenylglycol / Q000031:analogs & derivatives / Q000097:blood; D009638:Norepinephrine / Q000097:blood / Q000134:cerebrospinal fluid / Q000378:metabolism*; D011229:Preanesthetic Medication; D011897:Random Allocation; D014364:Tryptophan / Q000134:cerebrospinal fluid
chemical_list: D015102:3,4-Dihydroxyphenylacetic Acid; D008734:Methoxyhydroxyphenylglycol; D006897:Hydroxyindoleacetic Acid; D014364:Tryptophan; D003000:Clonidine; D003975:Diazepam; C010117:3,4-dihydroxyphenylglycol; D006854:Hydrocortisone; D009638:Norepinephrine; D004837:Epinephrine